combination of two previously approved cholesterol-lowering drugs, ezetimibe and atorvastatin.The drug, which will carry the brand name of Liptruzet, is a combination of two previously approvedLiptruzet will be available as a once-daily tablet combining 10 mg of ezetimibe with either 10, 20, 40...